European evidence-based consensus on the diagnosis and management of Crohn's disease

Gut

Volumn 56, Issue 2, 2007, Pages 161-163

  Hanauer, S B ^a,b   Sandborn, W J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PLACEBO; PREDNISOLONE; SALAZOSULFAPYRIDINE;

COLONOSCOPY; CROHN DISEASE; EDITORIAL; ENDOSCOPIC BIOPSY; EVIDENCE BASED MEDICINE; HUMAN; INTESTINE SURGERY; LONG TERM CARE; MEDICAL LITERATURE; OSTEOPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

CONSENSUS; CROHN DISEASE; EUROPE; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL AGENTS; HUMANS; ORGANIZATIONS; PRACTICE GUIDELINES;

EID: 33846946170     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.089953     Document Type: Editorial

References (4)

1. Stange EF, Trauis SPL, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006;55(Suppl I):i1-15.
2. Hanauer SB, Sandborn W. Management of Crohn's disease in adults. Am J Gastroenterol 2001;96:635-43.
3. Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal Crohn's disease. Gastroenterology 2003;125: 1508-30.
4. Sandborn WJ, Feagan BG. Review article: mild to moderate Crohn's disease - defining the basis for a new treatment algorithm. Aliment Pharmacol Ther 2003;18:263-77.